MedTrace Logo

Study on the microRNA Expression Level in Postmenopausal Osteoporosis

NCT02128009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-02-26

No results posted yet for this study

Summary

The miRNA plays an important regulation role in gene expression, and also closely related to bone metabolism. Previous research found that postmenopausal osteoporosis with kidney Yin deficiency syndrome (POP) is associated with CLCF1 gene. This project proposed by bioinformatics prediction CLCF1 targeted regulation of miRNAs, and use the 3 'UTR dual luciferase report system for target validation, aimed at the miRNA levels to explore postmenopausal osteoporosis molecular mechanism with kidney Yin deficiency syndrome.

Conditions

  • Postmenopausal Osteoporosis

Interventions

OTHER

osteoporosis

Sponsors & Collaborators

  • Fujian Academy of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • FJ ITCM, provincial · Fujian Institute of Trational Chiness Medicine

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-12-31
Completion
2017-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02128009 on ClinicalTrials.gov